KGP Laboratories (UK) Limited and Pskov Pharma LLC plan to establish in Moglino Special Economic Zone (SEZ) a high-tech production facility to manufacture a wide range of potent drugs for the treatment of oncological and other diseases. A corresponding investment project was reviewed on October 5 at the meeting of the Supervisory Board of Moglino SEZ chaired by the Governor of Pskov region Andrey Turchak.
The project is designed for implementation within 4 years (2018 – 2021). At the first stage, the investor plans to build a complex for full-cycle manufacturing of anti-tumor drugs in tablets, capsules, and liquid form aimed at destruction of malignant cells. The product range includes 10 items and will be expanded. The investments amount to 600 million rubles. The project provides for the processing units with zero-level pollution of the environment.
The plans for the second stage (2019 – 2020) include the construction of a building for manufacturing active pharmaceutical substances. The investments will be about 1.2 billion rubles. The third stage (2020 – 2021) provides for the construction of a building to manufacture veterinary drugs. The investments will be about 900 million rubles. The first stage involves the creation of 33 new jobs. When the plant will run at its full capacity, the number of new jobs will exceed one hundred.